Kraig Biocraft Laboratories Completes Key Spider Silk Production Cycle
ANN ARBOR, Mich. — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs") has announced the successful completion of its third commercial production cycle for spider silk. This cycle was specifically aimed at producing the Company's BAM-1 recombinant spider silk hybrids, marking the second successful phase of its most advanced spider silk innovations.
Production in Challenging Conditions
This production cycle took place during a particularly challenging rainy season, marked by high humidity and heavy rainfall, conditions that usually hinder the operations of most silk producers. Nevertheless, Kraig Labs made a strategic choice to continue with production, further testing the resilience and reliability of its BAM-1 hybrids.
Insights from Industry Experts
By operating under these adverse weather conditions, the Company seized the opportunity to improve its silkworm colony, identifying superior performers that are promising for future growth. Dr. Nirmal Kumar, a renowned expert in sericulture, collaborated with the production team to analyze the comprehensive data collected during this rearing cycle, providing recommendations to enhance the BAM-1 parental lines for ongoing success and growth in spider silk production.
Future Developments Post-Harvest
In the next two weeks, Kraig Labs plans to harvest the hybrid spider silk cocoons produced during this cycle and transport them to local reeling facilities. This batch will undergo further processing to refine reeling techniques, improve operational efficiency, and produce more finished spider silk for various market applications.
Company Insights
"The toughest challenge for robustness is operating during the rainy season. Our BAM-1 hybrids have demonstrated their ability to endure whatever nature presents," said Jon Rice, COO of the Company. "Our team continues to achieve new milestones in both production and processing, with the BAM-1 hybrids acting as catalysts for rapid and steady growth in our scalable and commercially viable spider silk production."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. is recognized as a leading biotechnology firm dedicated to developing advanced genetically engineered spider silk-based fiber technologies. The Company has made significant scientific advancements in spider silk technology, with the goal of transforming the global textile industry.
Contact Information
For further inquiries, please reach out to:
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
Frequently Asked Questions
1. What is the main achievement discussed in the article?
Kraig Biocraft Laboratories has successfully completed its third commercial spider silk production cycle, focusing on BAM-1 recombinant spider silk hybrids.
2. What unique conditions did the Company face during production?
The production cycle occurred during a rainy season, a period generally unfavorable for silk production due to high humidity and heavy rains.
3. Who collaborated with Kraig Labs during this production cycle?
Dr. Nirmal Kumar, a notable sericulture expert, worked with the production team to optimize spider silk production based on collected data.
4. What are the next steps after harvesting the cocoons?
After harvesting, the cocoons will be sent to local facilities for reeling to improve efficiency and produce more finished spider silk for market use.
5. How does Kraig Labs envision the future of its spider silk production?
The Company aims for rapid and consistent growth in scalable, commercially sustainable spider silk production, leveraging its BAM-1 hybrids.
